Work

Cost-effectiveness of on-demand rFVIIa vs prophylactic emicizumab in hemophilia a with inhibitors: clinical, QoL, and ICER-based field insights

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Pharmaceutical Health Services Research

DOI: 10.1093/jphsr/rmaf021

Authors: Baraa G Abdulraheem, Ali Azeez Al-Jumaili, Safa Mohammed Shaukat Mohammed Khalid

Institutions: University of Iowa, University of Baghdad, University of California, Davis

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7111311546

FWCI:

Cites: 29

Cited by:

Related to: